Lista de obras - Gema Moreno-Bueno - Dominio Público Uruguay

"New" molecular taxonomy in breast cancer

artículo científico publicado en 2008

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

artículo científico publicado en 2014

A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance

artículo científico publicado en 2011

A role for the Tgf-β/Bmp co-receptor Endoglin in the molecular oscillator that regulates the hair follicle cycle

scientific article published on 01 January 2019

A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

artículo científico publicado en 2015

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

artículo científico publicado en 2002

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

artículo científico publicado en 2016

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

artículo científico publicado en 2014

Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study.

artículo científico publicado en 2016

Cancer network activity associated with therapeutic response and synergism

artículo científico publicado en 2016

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

artículo científico publicado en 2010

Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer.

artículo científico publicado en 2008

Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

artículo científico publicado en 2016

Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

artículo científico publicado en 2008

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

artículo científico publicado en 2004

Contribution of Epithelial Plasticity to Therapy Resistance

scientific article published on 14 May 2019

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

artículo científico publicado en 2002

Cyclin D1 gene (CCND1) mutations in endometrial cancer

artículo científico publicado en 2003

Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma

artículo científico publicado en 2003

Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions

artículo científico publicado en 2004

Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.

artículo científico publicado en 2003

Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).

artículo científico publicado en 2005

E47 and Id1 interplay in epithelial-mesenchymal transition

artículo científico publicado en 2013

EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination

artículo científico publicado en 2014

EMT: Present and future in clinical oncology

artículo científico

Endometrial carcinoma: molecular alterations involved in tumor development and progression

artículo científico publicado en 2012

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability

article

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

artículo científico publicado en 2008

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas

scientific article published on 02 June 2006

Functional characterization of E- and P-cadherin in invasive breast cancer cells

artículo científico publicado en 2009

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

scientific article published on 22 July 2016

Gasdermin-B promotes invasion and metastasis in breast cancer cells

artículo científico publicado en 2014

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.

artículo científico publicado en 2006

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

artículo científico publicado en 2016

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition

artículo científico publicado en 2006

High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.

artículo científico publicado en 2006

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

artículo científico publicado en 2006

Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women

artículo científico publicado en 2001

ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth

artículo científico publicado en 2013

In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines

artículo científico publicado en 2017

Inactivation of the Candidate Tumor Suppressor Par-4 in Endometrial Cancer

Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner.

artículo científico publicado en 2007

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

artículo científico publicado en 2015

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression

artículo científico publicado en 2015

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

artículo científico publicado en 2019

Invasion Program of Normal and Cancer Stem Cells

scholarly article

Isolation and characterization of casein kinase I from Dictyostelium discoideum ⬇️

artículo científico publicado en 2000

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.

artículo científico publicado en 2008

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

artículo científico publicado en 2011

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition.

artículo científico publicado en 2014

LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway

artículo científico publicado en 2017

LOXL2 in epithelial cell plasticity and tumor progression

artículo científico publicado en 2012

Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors

artículo científico publicado en 2015

Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas

artículo científico publicado en 2006

Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer

artículo científico publicado en 2017

Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization

artículo científico publicado en 2014

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

artículo científico publicado en 2011

Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

artículo científico publicado en 2008

Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.

artículo científico publicado en 2015

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

artículo científico publicado en 2012

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

artículo científico publicado en 2012

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

artículo científico publicado en 2010

MicroRNA-dependent regulation of transcription in non-small cell lung cancer

artículo científico publicado en 2014

MicroRNAs as prognostic markers in ovarian cancer.

artículo científico

Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

artículo científico publicado en 2001

Molecular alterations associated with cyclin D1 overexpression in endometrial cancer

artículo científico publicado en 2004

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

artículo científico publicado en 2012

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

artículo científico publicado en 2014

Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.

artículo científico publicado en 2006

PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.

artículo científico publicado en 2008

Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases

artículo científico publicado en 2009

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.

artículo científico publicado en 2016

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.

artículo científico publicado en 2017

Re: Scholten et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465.

artículo científico publicado en 2004

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

artículo científico publicado en 2015

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

artículo científico publicado en 2014

SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells

artículo científico publicado en 2007

Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

scholarly article

Sin3b interacts with Myc and decreases Myc levels

artículo científico publicado en 2014

Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines

artículo científico publicado en 2008

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer

artículo científico publicado en 2007

Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study

artículo científico publicado en 2007

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

artículo científico publicado en 2016

Telling cells how to die: docetaxel therapy in cancer cell lines.

artículo científico publicado en 2007

The EMT signaling pathways in endometrial carcinoma.

artículo científico

The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells.

artículo científico publicado en 2014

The Ras-related gene ERAS is involved in human and murine breast cancer

artículo científico publicado en 2018

The class I bHLH factors E2-2A and E2-2B regulate EMT.

artículo científico publicado en 2009

The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes.

artículo científico publicado en 2015

The morphological and molecular features of the epithelial-to-mesenchymal transition

scientific article published on 15 October 2009

The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells

artículo científico publicado en 2011

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma

artículo científico publicado en 2001

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients

artículo científico publicado en 2016

The tumor suppressor ING1 contributes to epigenetic control of cellular senescence

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

scientific article published on 07 February 2019

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

artículo científico publicado en 2009

Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair (hMLH1 and hMSH2 Genes) in Endometrial Carcinoma and Atypical Endometrial Hyperplasia: Relationship with Microsatellite Instability

article

Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53.

artículo científico publicado en 2006

Transcriptional regulation of cell polarity in EMT and cancer

artículo científico publicado en 2008

Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

artículo científico publicado en 2017

Updating the role of obesity and cholesterol in breast cancer

artículo científico publicado en 2019

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

artículo científico publicado en 2006

Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

scientific article published on 12 September 2014

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas

artículo científico publicado en 2001

beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.

artículo científico publicado en 2001

β- And γ-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability

artículo científico publicado en 2001

β-Catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome

artículo científico publicado en 2000

Lista de obras de Gema Moreno-Bueno

"New" molecular taxonomy in breast cancer

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.

A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance

A role for the Tgf-β/Bmp co-receptor Endoglin in the molecular oscillator that regulates the hair follicle cycle

A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study.

Cancer network activity associated with therapeutic response and synergism

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer.

Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

Contribution of Epithelial Plasticity to Therapy Resistance

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

Cyclin D1 gene (CCND1) mutations in endometrial cancer

Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma

Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions

Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.

Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).

E47 and Id1 interplay in epithelial-mesenchymal transition

EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination

EMT: Present and future in clinical oncology

Endometrial carcinoma: molecular alterations involved in tumor development and progression

Epigenetic and genetic alterations ofAPCandCDH1genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas

Functional characterization of E- and P-cadherin in invasive breast cancer cells

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

Gasdermin-B promotes invasion and metastasis in breast cancer cells

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition

High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.

Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.

Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women

ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth

In1-ghrelin splicing variant is associated with reduced disease-free survival of breast cancer patients and increases malignancy of breast cancer cells lines

Inactivation of the Candidate Tumor Suppressor Par-4 in Endometrial Cancer

Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner.

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

Invasion Program of Normal and Cancer Stem Cells

Isolation and characterization of casein kinase I from Dictyostelium discoideum ⬇️

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition.

LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway

LOXL2 in epithelial cell plasticity and tumor progression

Loss of Snail2 favors skin tumor progression by promoting the recruitment of myeloid progenitors

Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas

Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer

Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

MicroRNA-dependent regulation of transcription in non-small cell lung cancer

MicroRNAs as prognostic markers in ovarian cancer.

Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

Molecular alterations associated with cyclin D1 overexpression in endometrial cancer

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.

PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.

Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells.

Re: Scholten et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465.

Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells